INCY Incyte Corporation
P/E
15.9
Forward P/E
14.53
Price/Sales
4.342
Beta
0.77
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Incyte Nears $2 Billion Star Therapeutics Deal, Targeting Bleeding Disorder Drug
Incyte is reportedly nearing a $2 billion acquisition of privately held Star Therapeutics. The agreement includes a $1.25 billion upfront cash payment....
🟢 Incyte Corporation is trading 4.4% up today as it extends a three-day rebound
Incyte Corporation is trading 4.4% up at $105.72 on momentum and dip-buying as the stock extends a three-day recovery from levels below $93. • The move...
🟢 Incyte Corporation is trading 4.4% up today, extending a three-day rebound despite broader market weakness
Incyte Corporation is trading 4.4% up at $105.67, extending a sharp three-day rebound from below $93 despite broader U.S. indices trading lower. • The move...